Claire L. Gordon
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 7
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
- Epidemiology top 5%
- Respiratory viral infections research 4
- Influenza Virus Research Studies 3
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
- Virology top 10%
- Co-authors
- Donna L. FärberHarvey LernerN. MatsuokaJoseph J.C. ThomeTomer GranotS. TozeAdam GriesemerPaul D. R. Johnson
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Claire L. Gordon
49 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 130
- Immunology 681
- Infectious Diseases 314
- Epidemiology 537
- Transplantation 25
- Virology 39
Countries citing papers authored by Claire L. Gordon
This map shows the geographic impact of Claire L. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire L. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire L. Gordon more than expected).
Fields of papers citing papers by Claire L. Gordon
This network shows the impact of papers produced by Claire L. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire L. Gordon. The network helps show where Claire L. Gordon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claire L. Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 35 | |
| 7 | 2021 | 11 | |
| 8 | 2018 | 41 | |
| 9 | 2018 | 4 | |
| 10 | 2017 | 101 | |
| 11 | 2017 | 45 | |
| 12 | 2016 | 4 | |
| 13 | 2015 | 48 | |
| 14 | 2015 | 10 | |
| 15 | 2015 | 9 | |
| 16 | 2012 | 42 | |
| 17 | 2012 | 6 | |
| 18 | Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis | 2010 | 1 |
| 19 | 2003 | 29 | |
| 20 | 2000 | 20 |
About Claire L. Gordon
Claire L. Gordon is a scholar working on Transplantation, Infectious Diseases and Immunology, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers), Respiratory viral infections research (4 papers), Influenza Virus Research Studies (3 papers) and Renal Transplantation Outcomes and Treatments (3 papers). The work is most often cited by research in Immunology (681 citations), Infectious Diseases (314 citations) and Epidemiology (537 citations). Claire L. Gordon has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Donna L. Färber, Harvey Lerner, N. Matsuoka, Joseph J.C. Thome, Tomer Granot, S. Toze, Adam Griesemer, Paul D. R. Johnson, Joshua Weiner and Michelle Miron. Their work appears in journals such as Nature Medicine, The Journal of Experimental Medicine and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.